DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Listen to this Section


$3.60
+0.0900 ( +2.56% ) 15.6K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$3.60

Previous close


$3.51

Volume


15.6K

Market cap


$153.89M

Day range


$3.46 - $3.61

52 week range


$1.94 - $3.81

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 02, 2024
4 Insider transactions 1 Nov 16, 2023
10-q Quarterly Reports 64 Nov 13, 2023
8-k 8K-related 22 Nov 13, 2023
8-k 8K-related 15 Sep 05, 2023
10-q Quarterly Reports 64 Aug 14, 2023
8-k 8K-related 15 Aug 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.